| Tango Therapeutics, Inc. | 1.22M | US$38.2M | 6.6% |
| Abivax Sa | 284K | US$37.8M | 6.5% |
| Revolution Medicines, Inc. | 160K | US$30M | 5.2% |
| Erasca, Inc. | 1.57M | US$28.7M | 4.9% |
| Tyra Biosciences, Inc. | 633K | US$20.2M | 3.5% |
| Dianthus Therapeutics, Inc. | 201K | US$19.6M | 3.4% |
| Enliven Therapeutics, Inc. | 347K | US$17.6M | 3.0% |
| Mineralys Therapeutics, Inc. | 603K | US$16.3M | 2.8% |
| Biohaven Ltd. | 1.06M | US$15.8M | 2.7% |
| Surrozen, Inc. | 603K | US$13.8M | 2.4% |
| Scholar Rock Holding Corporation | 239K | US$13.2M | 2.3% |
| First Tracks Biotherapeutics, Inc. | 623K | US$12.5M | 2.2% |
| Praxis Precision Medicines, Inc. | 37,243 | US$12.5M | 2.1% |
| Roivant Sciences Ltd. | 348K | US$12.3M | 2.1% |
| Bioage Labs, Inc. | 464K | US$11.4M | 2.0% |
| Cg Oncology, Inc. | 159K | US$11.3M | 2.0% |
| Oruka Therapeutics, Inc. | 116K | US$11.1M | 1.9% |
| Immunovant, Inc. | 277K | US$10.7M | 1.8% |
| Celcuity Inc. | 98,203 | US$10.3M | 1.8% |
| Relmada Therapeutics, Inc. | 1.46M | US$10.1M | 1.7% |
| Climb Bio, Inc. | 743K | US$9.69M | 1.7% |
| Spyre Therapeutics, Inc. | 107K | US$9.49M | 1.6% |
| Zura Bio Limited | 1.37M | US$8.07M | 1.4% |
| Amylyx Pharmaceuticals, Inc. | 384K | US$6.9M | 1.2% |
| Celldex Therapeutics, Inc. | 178K | US$6.64M | 1.1% |
| Ovid Therapeutics Inc. | 2.42M | US$6.5M | 1.1% |
| Equillium, Inc. | 2.02M | US$6.45M | 1.1% |
| Definium Therapeutics, Inc. | 137K | US$6.45M | 1.1% |
| Cytokinetics, Incorporated | 75,603 | US$6.44M | 1.1% |
| Damora Therapeutics, Inc. | 216K | US$5.62M | 0.97% |
| Inventiva Sa | 1.43M | US$5.39M | 0.93% |
| Century Therapeutics, Inc. | 2.15M | US$5.26M | 0.91% |
| Aura Biosciences, Inc. | 714K | US$5.07M | 0.87% |
| Eyepoint, Inc. | 338K | US$4.84M | 0.83% |
| Assembly Biosciences, Inc. | 170K | US$4.68M | 0.81% |
| Whitehawk Therapeutics, Inc. | 1.02M | US$4.68M | 0.81% |
| Xenon Pharmaceuticals Inc. | 76,075 | US$4.59M | 0.79% |
| Avalyn Pharma Inc. | 118K | US$3.88M | 0.67% |
| Maplight Therapeutics, Inc. | 107K | US$3.83M | 0.66% |
| Alumis Inc. | 136K | US$3.82M | 0.66% |
| Axsome Therapeutics, Inc. | 15,375 | US$3.76M | 0.65% |
| Monte Rosa Therapeutics, Inc. | 154K | US$3.72M | 0.64% |
| Acadia Pharmaceuticals Inc. | 143K | US$3.62M | 0.62% |
| Solid Biosciences Inc. | 359K | US$3.58M | 0.62% |
| Personalis, Inc. | 248K | US$3.32M | 0.57% |
| Crescent Biopharma, Inc. | 182K | US$3.28M | 0.57% |
| Arrowhead Pharmaceuticals, Inc. | 39,198 | US$3.2M | 0.55% |
| Kodiak Sciences Inc | 75,872 | US$2.96M | 0.51% |
| Monopar Therapeutics Inc. | 30,125 | US$2.79M | 0.48% |
| Rapport Therapeutics, Inc. | 66,582 | US$2.77M | 0.48% |
| Sionna Therapeutics, Inc. | 59,426 | US$2.61M | 0.45% |
| Arcutis Biotherapeutics, Inc. | 98,945 | US$2.59M | 0.45% |
| C4 Therapeutics, Inc. | 524K | US$2.45M | 0.42% |
| Spruce Biosciences, Inc. | 41,388 | US$2.23M | 0.38% |
| Cue Biopharma, Inc. | 66,995 | US$2.11M | 0.36% |
| Protagonist Therapeutics, Inc. | 16,303 | US$2M | 0.34% |
| Helix Acquisition Corp. Iii | 172K | US$1.83M | 0.31% |
| Biodesix, Inc. | 70,000 | US$1.58M | 0.27% |
| Tenax Therapeutics, Inc. | 96,273 | US$1.4M | 0.24% |
| Sab Biotherapeutics, Inc. | 343K | US$1.34M | 0.23% |
| Calcimedica, Inc. | 1.24M | US$1.2M | 0.21% |
| Lb Pharmaceuticals Inc | 31,785 | US$1.03M | 0.18% |
| Cellectar Biosciences, Inc. | 355K | US$987K | 0.17% |
| Vistagen Therapeutics, Inc. | 617K | US$17,276 | <0.01% |